Ctc LLC Eli Lilly & CO Transaction History

Ctc LLC

$163 Billion
Q4 2024

A detailed history of Ctc LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ctc LLC holds 4,264 shares of LLY stock, worth $3.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,264

Previous 2,238 90.53%

Holding current value

$3.96 Million

Previous $1.98 Million 66.04%

% of portfolio

0.0%

Previous 0.05%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 18, 2025	BUY	$727.2 - $932.06 $1.47 Million - $1.89 Million	2,026 Added 90.53%	4,264 $3.29 Million
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $9.84 Million - $12.2 Million	-12,739 Reduced 85.06%	2,238 $1.98 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $8.02 Million - $10.1 Million	11,068 Added 283.14%	14,977 $13.6 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.31 Million - $3.1 Million	3,909 New	3,909 $3.04 Million

Others Institutions Holding LLY

# of Institutions

4,278

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $883B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ctc LLC with notifications on news.

Account